Clinical trial
A Prospective, Randomized, Double-Blind Controlled Trial Comparing Total Arterial Grafting Versus Conventional Mixed Grafting in the Left Coronary Artery System During Coronary Artery Bypass Grafting (CABG)
NCT07057713 is registered in ClinicalTrials.gov with Second Hospital of Jilin University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized, Double-Blind Controlled Trial Comparing Total Arterial Grafting Versus Conventional Mixed Grafting in the Left Coronary Artery System During Coronary Artery Bypass Grafting (CABG)
- Lead sponsor
- Second Hospital of Jilin University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- August 1, 2026
- Completion date
- December 30, 2027
- Enrollment
- 400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
arterial graft, coronary artery bypass grafting, coronary artery disease, graft patency, major adverse cardiovascular events